ANDAOPHTHALMICSOLUTION/DROPS
Approved
Dec 2015
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
4
Clinical Trials (4)
Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects
Started Dec 2014
Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis
Started Apr 2011
Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients
Started Mar 2010
42 enrolled
Allergic Conjunctivitis
Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)
Started Jul 2008